171 related articles for article (PubMed ID: 16864905)
1. Detection of salivary interleukin 2 and interleukin 6 in patients with burning mouth syndrome.
Simcić D; Pezelj-Ribarić S; Grzić R; Horvat J; Brumini G; Muhvić-Urek M
Mediators Inflamm; 2006; 2006(1):54632. PubMed ID: 16864905
[TBL] [Abstract][Full Text] [Related]
2. Burning mouth syndrome and saliva: detection of salivary trace elements and cytokines.
Pekiner FN; Gümrü B; Demirel GY; Ozbayrak S
J Oral Pathol Med; 2009 Mar; 38(3):269-75. PubMed ID: 19141055
[TBL] [Abstract][Full Text] [Related]
3. Salivary levels of IL-1beta, IL-6, IL-8, and TNF-alpha in patients with burning mouth syndrome.
Suh KI; Kim YK; Kho HS
Arch Oral Biol; 2009 Sep; 54(9):797-802. PubMed ID: 19555923
[TBL] [Abstract][Full Text] [Related]
4. Opiorphin in burning mouth syndrome patients: a case-control study.
Salarić I; Sabalić M; Alajbeg I
Clin Oral Investig; 2017 Sep; 21(7):2363-2370. PubMed ID: 28013436
[TBL] [Abstract][Full Text] [Related]
5. Burning mouth syndrome: a therapeutic approach involving mechanical salivary stimulation.
de Souza FT; Amaral TM; dos Santos TP; Abdo EN; Aguiar MC; Teixeira AL; Kummer AM; Abreu MH; Silva TA
Headache; 2012 Jun; 52(6):1026-34. PubMed ID: 22084903
[TBL] [Abstract][Full Text] [Related]
6. Potential protein biomarkers for burning mouth syndrome discovered by quantitative proteomics.
Ji EH; Diep C; Liu T; Li H; Merrill R; Messadi D; Hu S
Mol Pain; 2017 Jan; 13():1744806916686796. PubMed ID: 28326926
[TBL] [Abstract][Full Text] [Related]
7. Proinflammatory cytokine levels in saliva in patients with burning mouth syndrome before and after treatment with low-level laser therapy.
Pezelj-Ribarić S; Kqiku L; Brumini G; Urek MM; Antonić R; Kuiš D; Glažar I; Städtler P
Lasers Med Sci; 2013 Jan; 28(1):297-301. PubMed ID: 22773117
[TBL] [Abstract][Full Text] [Related]
8. Salivary interleukin-6 and tumor necrosis factor-alpha in patients with burning mouth syndrome.
Boras VV; Brailo V; Lukac J; Kordić D; Blazić-Potocki Z
Oral Dis; 2006 May; 12(3):353-5. PubMed ID: 16700748
[TBL] [Abstract][Full Text] [Related]
9. MUC1 and Toll-like receptor-2 expression in burning mouth syndrome and oral lichen planus.
Kho HS; Chang JY; Kim YY; Kim Y
Arch Oral Biol; 2013 Jul; 58(7):837-42. PubMed ID: 23411403
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptides in saliva of subjects with burning mouth syndrome: a pilot study.
Borelli V; Marchioli A; Di Taranto R; Romano M; Chiandussi S; Di Lenarda R; Biasotto M; Zabucchi G
Oral Dis; 2010 May; 16(4):365-74. PubMed ID: 20233324
[TBL] [Abstract][Full Text] [Related]
11. Burning mouth syndrome (BMS): sialometric and sialochemical analysis and salivary protein profile.
de Moura SA; de Sousa JM; Lima DF; Negreiros AN; Silva Fde V; da Costa LJ
Gerodontology; 2007 Sep; 24(3):173-6. PubMed ID: 17696895
[TBL] [Abstract][Full Text] [Related]
12. Reduced sialyl-Lewis
Acharya S; Jin C; Bylund J; Shen Q; Kamali-Moghaddam M; Jontell M; Carlén A; Karlsson NG
Mol Omics; 2019 Oct; 15(5):331-339. PubMed ID: 31414088
[TBL] [Abstract][Full Text] [Related]
13. Potential salivary and serum biomarkers for burning mouth syndrome and their relationship with anxiety/depression.
Zhang Y; Ye S; Zhang Y; Sun H; Zhao X; Shen X; Wu L
J Dent Sci; 2024 Apr; 19(2):1052-1060. PubMed ID: 38618099
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of interleukin-1β and MUC7 genes in burning mouth syndrome.
Kim MJ; Kim J; Chang JY; Kim YY; Kho HS
Clin Oral Investig; 2017 Apr; 21(3):949-955. PubMed ID: 27246755
[TBL] [Abstract][Full Text] [Related]
15. The association of openness personality trait with stress-related salivary biomarkers in burning mouth syndrome.
de Souza FT; Kummer A; Silva ML; Amaral TM; Abdo EN; Abreu MH; Silva TA; Teixeira AL
Neuroimmunomodulation; 2015; 22(4):250-5. PubMed ID: 25322841
[TBL] [Abstract][Full Text] [Related]
16. Mineral and trace element analysis of saliva from patients with BMS: a cross-sectional prospective controlled clinical study.
López-Jornet P; Juan H; Alvaro PF
J Oral Pathol Med; 2014 Feb; 43(2):111-6. PubMed ID: 23869755
[TBL] [Abstract][Full Text] [Related]
17. Protein composition, adhesion, and agglutination properties of saliva in burning mouth syndrome.
Tammiala-Salonen T; Söderling E
Scand J Dent Res; 1993 Aug; 101(4):215-8. PubMed ID: 8362199
[TBL] [Abstract][Full Text] [Related]
18. Proteomics of the acid-soluble fraction of whole and major gland saliva in burning mouth syndrome patients.
Cabras T; Manconi B; Castagnola M; Sanna MT; Arba M; Acharya S; Ekström J; Carlén A; Messana I
Arch Oral Biol; 2019 Feb; 98():148-155. PubMed ID: 30496935
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Salivary Cortisol and α-amylase Levels and Psychological Profiles in Patients with Burning Mouth Syndrome.
Nosratzehi T; Salimi S; Parvaee A
Spec Care Dentist; 2017 May; 37(3):120-125. PubMed ID: 28112423
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of salivary oxidate stress biomarkers, nitric oxide and C-reactive protein in patients with oral lichen planus and burning mouth syndrome.
Tvarijonaviciute A; Aznar-Cayuela C; Rubio CP; Ceron JJ; López-Jornet P
J Oral Pathol Med; 2017 May; 46(5):387-392. PubMed ID: 27862315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
